Overview
Norway biogas technology supplier's Q1 revenue declined yr/yr as large contracts neared completion
Q1 EBITDA rose to NOK 23 million, compared to NOK 14 million last year
Order intake more than doubled, driven by new UK contracts; order backlog stable
Outlook
The company did not provide financial guidance
Result Drivers
CONTRACT COMPLETION - Revenue declined as several large contracts neared completion, according to the company
GROSS MARGIN & SOLUTIONS SEGMENT - EBITDA rose, supported by a higher gross margin and a stronger contribution from the Solutions segment
ORDER INTAKE - Order intake more than doubled, mainly driven by two equipment-delivery contracts for new solids treatment hubs in the UK
Company press release: ID:nObiwmW1Ha
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
NOK 179 mln
Q1 EBITDA
NOK 23 mln
Q1 Orders
NOK 348 mln
Analyst Coverage
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the water & related utilities peer group is "buy."
Wall Street's median 12-month price target for Cambi ASA is NOK30.00, about 39.5% above its May 11 closing price of NOK21.50
The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 26 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)